T Rowe Price
TROW

$101.69

2.37%

Market Cap: $22.6B

About: T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load US and international stock, hybrid, bond, and money market funds. At the end of July 2024, the firm had $1.587 trillion in managed assets, composed of equity (51%), balanced (34%), fixed-income and money market (12%), and alternative (3%) offerings. Approximately two thirds of managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a US-based asset manager, deriving just under 9% of its AUM from overseas.

Employees: 7,929

Financials Security & Commodity Brokers, Dealers, Exchanges & Services

0

Funds holding %

of 6,686 funds

0

Analysts bullish %

of 10 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

17% more first-time investments, than exits

New positions opened: 90 | Existing positions closed: 77

14% more repeat investments, than reductions

Existing positions increased: 414 | Existing positions reduced: 364

10% more call options, than puts

Call options by funds: $252M | Put options by funds: $228M

1% more funds holding

Funds holding: 1,031 [Q1] → 1,044 (+13) [Q2]

1.6% less ownership

Funds ownership: 74.32% [Q1] → 72.72% (-1.6%) [Q2]

8% less capital invested

Capital invested by funds: $20.2B [Q1] → $18.7B (-$1.52B) [Q2]

18% less funds holding in top 10

Funds holding in top 10: 11 [Q1] → 9 (-2) [Q2]

See Fund Rankings

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$86

15%

downside

Avg. target

$111

9%

upside

High target

$123

21%

upside

10 analyst ratings

0 positive

0%

7 neutral

70%

3 negative

30%

Evercore ISI Group Glenn Schorr 73% 1-year accuracy 16 / 22 met price target	6%upside $108	In-Line Maintained	5 Sept 2024
Barclays Benjamin Budish 69% 1-year accuracy 42 / 61 met price target	3%downside $99	Underweight Initiated	27 Aug 2024
Deutsche Bank Brian Bedell 57% 1-year accuracy 13 / 23 met price target	11%upside $113	Hold Maintained	15 Aug 2024
TD Cowen Bill Kirk 45% 1-year accuracy 10 / 22 met price target	16%upside $118	Hold Maintained	29 Jul 2024
Deutsche Bank Brian Bedell 57% 1-year accuracy 13 / 23 met price target	10%upside $112	Hold Maintained	29 Jul 2024

See Analyst Rankings

Financial journalist opinion

Based on 8 articles about TROW published over the past 30 days

24/7 Wall Street

5 Highest-Yielding Dividend Aristocrats Can Explode Higher as Rates Cuts Begin

24/7 Wall St. Insights The market has fully priced in a 25-basis-point rate cut in September.

5 Highest-Yielding Dividend Aristocrats Can Explode Higher as Rates Cuts Begin

10 Dividend Blue-Chip Bargains To Potentially Profit From This Irrational Market Freakout

Joel Greenblatt's Magic Formula combines value and quality investing. By focusing on earnings yield and return on capital, it has achieved 40% annual returns for 21 years. The market's recent selloff, driven by weak manufacturing data, is an opportunity to buy high-quality undervalued dividend blue-chip stocks using Joel Greenblatt's Magic Formula. September's market volatility is average. Focus on long-term investment strategies rather than knee-jerk reactions to short-term data.

10 Dividend Blue-Chip Bargains To Potentially Profit From This Irrational Market Freakout

OHA is Administrative Agent and Sole Lender for Emergent BioSolutions Debt Refinancing

New York, New York, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Oak Hill Advisors (“OHA”) served as Administrative Agent and sole lender of a $250 million term loan facility supporting Emergent BioSolutions Inc. (“Emergent”) (NYSE: EBS), a global company providing life-saving and life-extending products that address public health threats. The new debt financing will refinance Emergent's existing credit facility, reaching a significant step in its multi-year plan to stabilize its financial profile.

OHA is Administrative Agent and Sole Lender for Emergent BioSolutions Debt Refinancing

The Motley Fool

This 4.6% Yielding Finance Stock Raised Its Dividend Through the Past 4 Recessions

T. Rowe Price grows along with the broader stock market. The company is highly profitable and maintains a strong balance sheet.

This 4.6% Yielding Finance Stock Raised Its Dividend Through the Past 4 Recessions

My Best Dividend Aristocrats For September 2024

The ProShares S&P 500 Dividend Aristocrats ETF kicks off the second half of 2024 with a bang, posting a gain of 5.15% in July. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 37 months of tracking these strategies, two strategies are outperforming NOBL, while 1 remains marginally behind.

My Best Dividend Aristocrats For September 2024

Zacks Investment Research

T. Rowe Price (TROW) is a Top Dividend Stock Right Now: Should You Buy?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes?

T. Rowe Price (TROW) is a Top Dividend Stock Right Now: Should You Buy?

T. ROWE PRICE ANNOUNCES ADDITION OF TAYLOR PIDGEON TO EXPAND CANADIAN RETIREMENT DISTRIBUTION BUSINESS

Pidgeon to serve as Vice President, Defined Contribution, focused on sales, client service, and consultant relations BALTIMORE , Aug. 21, 2024 /PRNewswire/ -- T. Rowe Price (Canada), Inc., announced that it has hired Taylor Pidgeon, CFA, as vice president for Defined Contribution in Canada.

T. ROWE PRICE ANNOUNCES ADDITION OF TAYLOR PIDGEON TO EXPAND CANADIAN RETIREMENT DISTRIBUTION BUSINESS

Zacks Investment Research

T. Rowe Price (TROW) Records 1.1% Sequential Rise in July AUM

T. Rowe Price (TROW) reports an AUM of $1.59 trillion at the end of July 2024, rising 1.1% from the previous month's level.

T. Rowe Price (TROW) Records 1.1% Sequential Rise in July AUM

Zacks Investment Research

This is Why T. Rowe Price (TROW) is a Great Dividend Stock

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes?

This is Why T. Rowe Price (TROW) is a Great Dividend Stock

Zacks Investment Research

Here's Why T. Rowe Price (TROW) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why T. Rowe Price (TROW) is a Strong Value Stock

See News Rankings